v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Condensed Consolidated Statements of Operations    
Revenue $ 1,101  
Operating expenses:    
Research and development 9,628 $ 8,265
General and administrative 3,086 2,371
Total operating expenses 12,714 10,636
Loss from operations (11,613) (10,636)
Other income, net 98 48
Net loss (11,515) (10,588)
Accrued dividends on preferred stock   (1,737)
Net loss applicable to common stockholders $ (11,515) $ (12,325)
Net loss per share applicable to common stockholders - basic and diluted $ (0.49) $ (5.15)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 23,393,448 2,394,470

Source